Where Do the New Drugs Fit in for Relapsed/Refractory Hodgkin Lymphoma?
Crossref DOI link: https://doi.org/10.1007/s11899-017-0384-z
Published Online: 2017-05-09
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Khan, Niloufer
Moskowitz, Alison J.
License valid from 2017-05-09